Reducing Side Effects of Chloroquine with <i>Medicinal Synthetic Aluminum-Magnesium Silicate</i>&reg;[Msams: Al<sub>4</sub>(SiO<sub>4</sub>)<sub>3</sub>+ 3Mg<sub>2</sub>SiO<sub>4</sub>→2Al<sub>2</sub>Mg<sub>3</sub>(SiO<sub>4</sub>)<sub>3</sub>] before Assessing Its Anti-Covid-19 Efficacy  

Reducing Side Effects of Chloroquine with <i>Medicinal Synthetic Aluminum-Magnesium Silicate</i>&reg;[Msams: Al<sub>4</sub>(SiO<sub>4</sub>)<sub>3</sub>+ 3Mg<sub>2</sub>SiO<sub>4</sub>→2Al<sub>2</sub>Mg<sub>3</sub>(SiO<sub>4</sub>)<sub>3</sub>] before Assessing Its Anti-Covid-19 Efficacy

在线阅读下载全文

作  者:Maduike Ezeibe Favour Onyeachonam Ijeoma Ogbonna Clara Akpan Mary Sanda Ekenma Kalu Njoku Njoku Munachi Udobi Ugochukwu Agu 

机构地区:[1]College of Veterinary Medicine, M’ichael Okpara University of Agriculture, Umudike, Nigeria [2]Directorate of Information Computer Technology, Michael Okpara University of Agriculture, Umudike, Nigeria

出  处:《Health》2020年第4期368-377,共10页健康(英文)

摘  要:To reduce Chloroquine’s (CQ) side effects, so that increasing its duration for anti-Covid-19 trials could be safe, the drug was potentiated by stabilizing it with Medicinal synthetic Aluminum-magnesium silicate (MSAMS). CQ-treatment for five Plasmodium berghie-infected mice-groups were: 7 mg/kg (normal dose);7 mg/kg (CQ-MSAMS);7 mg/kg (CQ-MSAMS + B-vitamins), 5.25 mg/kg (CQ-MSAMS + B-vitamins) and the control. Means of parasitaemia, 42.00 ± 15.74 of the normal-dose group, 37.22 ± 11.88 of the 7 mg/kg (CQ-MSAMS) group and 33.57 ± 12.62 of the 7 mg/kg (CQ-MSAMS + B-vitamins) group showed no significant (P ≥ 0.05) reduction from 52.50 ± 11.99 of the control, but the 5.25 mg/kg (CQ-MSAMS + B-vitamins) dose, cleared (P ≤ 0.01) the parasiteamia (00.00 ± 00.00), showing that MSAMS-potentiated Chloroquine, has best efficacy at 75% of the recommended dose. Fever and anemia were absent at that 5.25 mg/kg, suggesting that lower doses of CQ have reduced side effects.To reduce Chloroquine’s (CQ) side effects, so that increasing its duration for anti-Covid-19 trials could be safe, the drug was potentiated by stabilizing it with Medicinal synthetic Aluminum-magnesium silicate (MSAMS). CQ-treatment for five Plasmodium berghie-infected mice-groups were: 7 mg/kg (normal dose);7 mg/kg (CQ-MSAMS);7 mg/kg (CQ-MSAMS + B-vitamins), 5.25 mg/kg (CQ-MSAMS + B-vitamins) and the control. Means of parasitaemia, 42.00 ± 15.74 of the normal-dose group, 37.22 ± 11.88 of the 7 mg/kg (CQ-MSAMS) group and 33.57 ± 12.62 of the 7 mg/kg (CQ-MSAMS + B-vitamins) group showed no significant (P ≥ 0.05) reduction from 52.50 ± 11.99 of the control, but the 5.25 mg/kg (CQ-MSAMS + B-vitamins) dose, cleared (P ≤ 0.01) the parasiteamia (00.00 ± 00.00), showing that MSAMS-potentiated Chloroquine, has best efficacy at 75% of the recommended dose. Fever and anemia were absent at that 5.25 mg/kg, suggesting that lower doses of CQ have reduced side effects.

关 键 词:ANTIVIRAL Treatment with CHLOROQUINE Lower Doses Reduction of Side Effects MSAMS 

分 类 号:R73[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象